Abstract

Orlistat, an anti-obesity drug, has two critical issues—the first is its low efficacy due to low water solubility and the second is side effects such as oily spotting due to its lipase inhibition. The present study was designed to propose a solution using a formulation with mesoporous silica to simultaneously overcome two issues. Orlistat was loaded onto mesoporous silica by the supercritical melt-adsorption (SCMA) method, using carbon dioxide (CO2). Various types of mesoporous silica were used as adsorbents, and the effects of the pore volume, diameter and particle size of mesoporous silica on the pharmaceutical characteristics were evaluated by various solid-state characterization methods and in vitro and in vivo studies in relation to pharmacological efficacy and the improvement of side effects. The results showed that the pore volume and diameter determine loadable drug amount inside pores and crystallinity. The dissolution was significantly influenced by crystallinity, pore diameter and particle size, and the inhibition of lipase activity was in proportion to the dissolution rate. In vivo studies revealed that the serum triglyceride (TG) concentration was significantly decreased in the group administered amorphous orlistat-loaded Neuisilin®UFL2 with the highest in vitro dissolution rate and lipase activity inhibition in comparison to the commercial product. Furthermore, oily spotting tests in rats revealed that undigested oil was adsorbed onto mesoporous silica after orlistat was released in the gastro-intestinal tract, and it correlated with in vitro result that oil adsorption capacity was dependent on the surface area of empty mesoporous silica. Therefore, it was concluded that mesoporous silica type plays a major role in determining the pharmaceutical characteristics of orlistat formulation prepared using SCMA with CO2 for improving the low solubility and overcoming the side effects.

Highlights

  • Introduction1. IntroductionOrlistat (tetrahydrolipstatin), derived from lipstatin, a natural product of Streptomyces toxyricini, is a cOovrlaisletantt(itnehtriabhityodrrooflidpisgtaetsitniv),edleipriavseeds f(rFoigmurliep1st)a[t1in,2,]a. Onarltiusrtaatl pinrhoidbuitcst tohfeShtryedptroomlyysciessotofxdyireitcainryi, itsriaglcyocvearildenest i(nThGib)itboyr ocof vdaigleensttliyveblliopcaksiensg(Fthigeulriepa1s)e[1a,2ct]i.vOe rsliisteta, tainndhitbhiutssthreedhuycdesrotlhyesissuobfsdeiqeutaernyt tirnitgelsytcienraildeasb(sToGrp)tbioyncoovfatlhenetllyipbolloycskisinpgrtohdeulicptas,sesuaccthivaessimteo, annodgltyhcuesrridedesucaensdthfereseubfsaettqyueancitdins.teIsttiancatsl alobcsaolrlpytiionnthofetghaesltirpooinlytseisstipnraoldturacctst, wsuhcehnaasdmmoinnoisgtlryacteerdidwesitahnad mfreeealfa[t3t]y. aTchidesc.oImt amctesrlcoiacal lplyroinduthcet, gXaesntricoainl®te(sRtioncahletraPcht awrmheanceaudtmicianlsis,trNatuetdlewy,ithNaJ,mUeaSlA[3),]. wThaes caopmpmroevrecidal bpyrodthuect,FXoeondicaaln®d(RDocrhueg PAhdamrminaicsteruattiicoanls(,FNDuAt)leiny,1N99J,9UanSAd )it, wwaass sawppitrcohveeddtobyovtehretFhoeocdouanntderD(OruTgCA) idnm20in0i8st[r4a–t6io].nIt(hFaDsAb)eeinn 1w9i9d9ealyndusietdwaassasnwaitncthi-eodbetositoyvderruthgealcloouvnetrerth(eOTwCo)rlidn a2n0d08m[a4n–6y].clIint ihcaasl sbteuedniews ihdaevley suhsoewd nasthaant aonrltiis-toabtehsaitsypdorsuitgivaellpohvaerrmthaceowloogrilcdalaenfdficmacaynysucclhinaicsaclhsotuledsiteesrohlaavnedsThoGwrnedtuhcattioonrliasstawt ehlal saspwoseitigivhet plohsasrm[7a].coHloogwiceavleerffi, tchaecyusseucohf aosrlcishtoalteshtaesrotlwaondmTaGjorreidssuucetisotnhaast wneeeldl atsowbeeigohvtelrocsosm[7e].. THhoewfiervset ri,sthites uloswe osfoolurlbisiltiattyh. aOsrtlwistoatmisajaorbiisospuheasrtmhaatcneueetidcstoclbaessoifviecractoiomnes.yTshteemfircsltaisss iItIs dlorwugsowluitbhilliotyw. -Osorlliusbtailtitiys aanbdiophhigahrm-paecrmeuetaicbsilcitlayss[i8fi].caTtihouns,sytshteemslocwlassdiIsIsdorluugtiownitrhaltoewo-fsoolrulibsitlaittylaimnditshiigtsh-ppheramrmeaabcoilliotygi[c8a]l. Tahctuivs,ittyhe[9s–lo1w1].dAisnsooltuhteironsigrantiefiocfanortliissstauteliims tithseitssidpehaerffmecatcsoalosgsoiccailataecdtivwitiyth[9t–h1e1u].sAe nofotohrelirsstaigtn[1ifi2c]a. nInt imssouset icslitnhiecaslidsetuedffieecst,sthasessoicdieateefdfewctisthofthoerluissteaot,fsourclhistaast o[1il2y].sIpnomttionsgt,cfleincaiclaul rsgtuendcieys,,ftahtetys/iodielyesffteocotls, oofiloyrleisvtaact,usauticohn,asfeocialyl sinpcoottnitnign,enfeccea,l iunrcgreenasceyd, fadtteyfe/ocailtyiosnto, odl,iaorirlhyeeav, aacnudatiaobnd, ofemcainl ainl cpoanitninewnecree, ionbcsreeravseedd [d1e3f]e. cSaetvioenra, ldsitaurdrhieesa,haanvde baebednomcairnriaeldpoaiunt winearne oabttseemrvpetdto[1f3in].dSwevaeyrsatlostruedduiecsehtahveseebseiedne ceaffrercietsd, souucthinasa:ni)autsteemofpat stourfifancdtawntatyossttoabreildizuectehtehoeisle/wsiadteereiffnetecrtsfa, cseucinhoarsd: e(ri)touspereovfeanstucrofaalcetsacnetntcoe sotfatbhielizoeiltehmeuolisli/ownaitnerthinetceorfloacne; iiin) eonrhdaenr cteompernevt eonf twcaotaelrevsicsecnocseitoyfinthteheoicloelomnutlosiroenduinceththeecionltoenn;s(iitiy) eannhdafnrceeqmueennctyofowf adtreorpvleistc-dosroitpyleint tihnetecroaclotinontos,rethdeurceebythreeidnutecninsgitythaendprforebqaubeilnitcyy ooff cdoraolpelsecte-dncroe;pilieit) ipnhteyrsaiccatilonabs,sothrpetrieobny oref douilcinbgy tahelipporopbhailbicilitcyomofpcoouanldes; cievn)cein; c(riieia)spinhgystihcael naabtsuorrapltisotnooolf moialsbsybay lfiapcoilpithaitliincgcobmacpteoruianldg;r(oivw)thinicnretahseincgoltohne [n1a4t–u1r8a]l. sTthoeolsimdeasesffbeyctfsaacirleitacatiunsgedbabcytetrhiael mgreocwhathnisinmthbey cwohloicnh[1o4r–li1s8ta].t Tinhheibsiitdseliepffaescet.s are caused by the mechanism by which orlistat inhibits lipase.FFiigguurree 11.. Chemical structure of orlistaatt

  • Orlistat was loaded onto five types of mesoporous silica with various surface areas, pore volumes, and diameters by the supercritical melt-adsorption (SCMA) method using SC-CO2

  • The results showed that orlistat was successfully loaded onto mesoporous silica in an amorphous state in all types of mesoporous

Read more

Summary

Introduction

1. IntroductionOrlistat (tetrahydrolipstatin), derived from lipstatin, a natural product of Streptomyces toxyricini, is a cOovrlaisletantt(itnehtriabhityodrrooflidpisgtaetsitniv),edleipriavseeds f(rFoigmurliep1st)a[t1in,2,]a. Onarltiusrtaatl pinrhoidbuitcst tohfeShtryedptroomlyysciessotofxdyireitcainryi, itsriaglcyocvearildenest i(nThGib)itboyr ocof vdaigleensttliyveblliopcaksiensg(Fthigeulriepa1s)e[1a,2ct]i.vOe rsliisteta, tainndhitbhiutssthreedhuycdesrotlhyesissuobfsdeiqeutaernyt tirnitgelsytcienraildeasb(sToGrp)tbioyncoovfatlhenetllyipbolloycskisinpgrtohdeulicptas,sesuaccthivaessimteo, annodgltyhcuesrridedesucaensdthfereseubfsaettqyueancitdins.teIsttiancatsl alobcsaolrlpytiionnthofetghaesltirpooinlytseisstipnraoldturacctst, wsuhcehnaasdmmoinnoisgtlryacteerdidwesitahnad mfreeealfa[t3t]y. aTchidesc.oImt amctesrlcoiacal lplyroinduthcet, gXaesntricoainl®te(sRtioncahletraPcht awrmheanceaudtmicianlsis,trNatuetdlewy,ithNaJ,mUeaSlA[3),]. wThaes caopmpmroevrecidal bpyrodthuect,FXoeondicaaln®d(RDocrhueg PAhdamrminaicsteruattiicoanls(,FNDuAt)leiny,1N99J,9UanSAd )it, wwaass sawppitrcohveeddtobyovtehretFhoeocdouanntderD(OruTgCA) idnm20in0i8st[r4a–t6io].nIt(hFaDsAb)eeinn 1w9i9d9ealyndusietdwaassasnwaitncthi-eodbetositoyvderruthgealcloouvnetrerth(eOTwCo)rlidn a2n0d08m[a4n–6y].clIint ihcaasl sbteuedniews ihdaevley suhsoewd nasthaant aonrltiis-toabtehsaitsypdorsuitgivaellpohvaerrmthaceowloogrilcdalaenfdficmacaynysucclhinaicsaclhsotuledsiteesrohlaavnedsThoGwrnedtuhcattioonrliasstawt ehlal saspwoseitigivhet plohsasrm[7a].coHloogwiceavleerffi, tchaecyusseucohf aosrlcishtoalteshtaesrotlwaondmTaGjorreidssuucetisotnhaast wneeeldl atsowbeeigohvtelrocsosm[7e].. THhoewfiervset ri,sthites uloswe osfoolurlbisiltiattyh. aOsrtlwistoatmisajaorbiisospuheasrtmhaatcneueetidcstoclbaessoifviecractoiomnes.yTshteemfircsltaisss iItIs dlorwugsowluitbhilliotyw. -Osorlliusbtailtitiys aanbdiophhigahrm-paecrmeuetaicbsilcitlayss[i8fi].caTtihouns,sytshteemslocwlassdiIsIsdorluugtiownitrhaltoewo-fsoolrulibsitlaittylaimnditshiigtsh-ppheramrmeaabcoilliotygi[c8a]l. Tahctuivs,ittyhe[9s–lo1w1].dAisnsooltuhteironsigrantiefiocfanortliissstauteliims tithseitssidpehaerffmecatcsoalosgsoiccailataecdtivwitiyth[9t–h1e1u].sAe nofotohrelirsstaigtn[1ifi2c]a. nInt imssouset icslitnhiecaslidsetuedffieecst,sthasessoicdieateefdfewctisthofthoerluissteaot,fsourclhistaast o[1il2y].sIpnomttionsgt,cfleincaiclaul rsgtuendcieys,,ftahtetys/iodielyesffteocotls, oofiloyrleisvtaact,usauticohn,asfeocialyl sinpcoottnitnign,enfeccea,l iunrcgreenasceyd, fadtteyfe/ocailtyiosnto, odl,iaorirlhyeeav, aacnudatiaobnd, ofemcainl ainl cpoanitninewnecree, ionbcsreeravseedd [d1e3f]e. cSaetvioenra, ldsitaurdrhieesa,haanvde baebednomcairnriaeldpoaiunt winearne oabttseemrvpetdto[1f3in].dSwevaeyrsatlostruedduiecsehtahveseebseiedne ceaffrercietsd, souucthinasa:ni)autsteemofpat stourfifancdtawntatyossttoabreildizuectehtehoeisle/wsiadteereiffnetecrtsfa, cseucinhoarsd: e(ri)touspereovfeanstucrofaalcetsacnetntcoe sotfatbhielizoeiltehmeuolisli/ownaitnerthinetceorfloacne; iiin) eonrhdaenr cteompernevt eonf twcaotaelrevsicsecnocseitoyfinthteheoicloelomnutlosiroenduinceththeecionltoenn;s(iitiy) eannhdafnrceeqmueennctyofowf adtreorpvleistc-dosroitpyleint tihnetecroaclotinontos,rethdeurceebythreeidnutecninsgitythaendprforebqaubeilnitcyy ooff cdoraolpelsecte-dncroe;pilieit) ipnhteyrsaiccatilonabs,sothrpetrieobny oref douilcinbgy tahelipporopbhailbicilitcyomofpcoouanldes; cievn)cein; c(riieia)spinhgystihcael naabtsuorrapltisotnooolf moialsbsybay lfiapcoilpithaitliincgcobmacpteoruianldg;r(oivw)thinicnretahseincgoltohne [n1a4t–u1r8a]l. sTthoeolsimdeasesffbeyctfsaacirleitacatiunsgedbabcytetrhiael mgreocwhathnisinmthbey cwohloicnh[1o4r–li1s8ta].t Tinhheibsiitdseliepffaescet.s are caused by the mechanism by which orlistat inhibits lipase.FFiigguurree 11.. Chemical structure of orlistaatt.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call